Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples